Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AURA stock hub

Aura Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AURAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

871.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AURA

In the news

Latest news · AURA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-73.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-43.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AURA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001501796
Company name	Aura Biosciences, Inc.
Country	United States
Country code	US
Cusip	05153U107
Employees	113
Employees Change	4%
Employees Change Percent	3.67
Enterprise value	$745M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-29
Isin	US05153U1079
Last refreshed	2026-05-10
Market cap	$871.8M
Market cap category	Small-Cap
Price	$8.4
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	AURA
Website	https://www.aurabiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.18%
FCF yield	-9.77%
P/B ratio	3.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-106.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-939,743
ROA	-40.06
Roa5y	-26.7
ROCE	-74.67
ROE	-73.52
Roe5y	-46.13
ROIC	-43.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	69.08%
Cagr3y	-4.71%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$169.4M
Cash	$144.2M
Current Assets	$149.7M
Current Liabilities	$18.4M
Debt	$17.4M
Debt Equity	$0.13
Equity	$136.9M
Liabilities	$32.5M
Long Term Assets	$19.7M
Long Term Liabilities	$14.1M
Net Cash	$126.9M
Net Cash By Market Cap	$14.55
Net Cash Growth	-4.13%
Net Debt Equity	$-0.93
Tangible Book Value	$136.9M
Tangible Book Value Per Share	$2.15
WACC	6.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.15
Net Working Capital	$-9.6M
Quick ratio	7.85
Working Capital	$131.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	69.01%
200-day SMA	6.19
3Y total return	-13.49%
50-day SMA	6.77
50-day SMA vs 200-day SMA	50over200
All Time High	26.16
All Time High Change	-67.89%
All Time High Date	2021-11-16
All Time Low	4.35
All Time Low Change	93.33%
All Time Low Date	2025-05-15
ATR	0.5
Beta	0.37
Beta1y	1.67
Beta2y	1.49
Ch YTD	54.13
High	8.46
High52	9.54
High52 Date	2026-05-05
High52ch	-11.9%
Low	8.06
Low52	4.35
Low52 Date	2025-05-15
Low52ch	93.33%
Ma50ch	24.1%
Price vs 200-day SMA	35.68%
RSI	65.32
RSI Monthly	53.79
RSI Weekly	70.14
Sharpe ratio	1.08x
Sortino ratio	1.97
Total Return	-21.53%
Tr YTD	54.13
Tr1m	26.7%
Tr1w	19.83%
Tr3m	50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$21.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.4
Operating Income	$-112.8M
Price target	$20
Price Target Change	$138
Price Target Change Top	$158

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,159,709%
Float Percent	35.8%
Shares Insiders	1.1%
Shares Institutions	27.43%
Shares Out	103,790,778
Shares Qo Q	1.76%
Shares Yo Y	21.53%
Short Float	5.42%
Short Ratio	6.43
Short Shares	1.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-99.5M
Average Volume	720,018.3x
Bv Per Share	2.15
CAPEX	$-447,000
Ch1m	26.7
Ch1w	19.83
Ch1y	69.01
Ch3m	50
Ch3y	-13.49
Ch6m	57.01
Change	2.44%
Change From Open	3.07
Close	8.2
Days Gap	-0.61
Depreciation Amortization	1,129,000
Dollar Volume	8,802,796.8
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-112.8M
EBITDA	$-111.7M
EPS	$-1.76
F Score	1
FCF	$-85.2M
FCF EV Yield	-11.44x
FCF Per Share	$-0.82
Financing CF	77,155,000
Fiscal Year End	December
Founded	2,007
Income Tax	$108,000
Investing CF	35,595,000
Ipr	-40
Iprfo	-40.43
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	6.09
Ma150ch	37.91%
Ma20	7.44
Ma20ch	12.9%
Net CF	27,822,000
Next Earnings Date	2026-05-22
Open	8.15
Optionable	Yes
Position In Range	85
Post Close	8.4
Postmarket Change Percent	-0.12
Postmarket Price	$8.39
Ppne	18,452,000
Price Date	2026-05-08
Ptbv Ratio	6.37
Relative Volume	1.46x
Share Based Comp	14,317,000
Tr6m	57.01%
Us State	Massachusetts
Volume	1,047,952

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AURA pay a dividend?

Capital-return profile for this ticker.

Performance

AURA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AURA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.4%

Float: +35.8% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AURA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.3

Neutral momentum band

Price vs 200-day MA

+35.7%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AURA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AURA stock rating?

Aura Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AURA analysis?

The full report lives at /stocks/AURA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AURA?

The latest report frames AURA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AURA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.